UK & Europe Pfizer's Lyrica patent appeal fails in UK Generics firms free to exploit gap in Pfizer's patent defences.
News Pfizer finally decides not to split up company Company will remain as one, but Read keeps his options open
News Pfizer's breast cancer drug step closer to EU approval Ibrance is already Pfizer's top oncology product.
Views & Analysis Digital Health Round-up – Verily's diabetes ambitions; IBM W... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
News Pfizer to buy AstraZeneca antibiotics for up to $1.5bn AZ continues to sell off already marketed drugs.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
